Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Amines. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102304007B reveals high-ee asymmetric hydrogenation using chiral Ru catalysts enabling cost reduction in pharmaceutical intermediate manufacturing with scalable processes.